Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment

J Alzheimers Dis. 2006 Dec;10(4):391-7. doi: 10.3233/jad-2006-10407.

Abstract

Objective: To identify oxidatively modified proteins in brains of persons with inherited Alzheimer's disease.

Methods: Redox proteomics was used to identify oxidatively modified brain proteins in persons with mutations in the genes for presenilin-1 (PS-1).

Results: An initial redox proteomics assessment of oxidatively modified proteins from brains of individuals with PS-1 mutations was performed. These PS1 mutations, Q222H and M233T, are completely penetrant causing early-onset familial AD as previously reported in these Australian families. We show that oxidative modifications of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), gamma-enolase, actin, and dimethylarginine dimethylaminohydrolase 1 (DMDMAH-1) are present in the brain of familial AD subjects.

Conclusions: These initial results suggest that oxidatively modified proteins are important common features in both familial and sporadic AD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / physiopathology
  • Amidohydrolases / genetics
  • Brain / metabolism
  • Gene Expression Regulation / physiology
  • Humans
  • Oxidation-Reduction
  • Oxidative Stress / genetics*
  • Oxidative Stress / physiology
  • Phosphopyruvate Hydratase
  • Presenilin-1 / genetics*
  • Proteomics*
  • Ubiquitin Thiolesterase / genetics

Substances

  • Actins
  • Presenilin-1
  • UCHL1 protein, human
  • Ubiquitin Thiolesterase
  • Amidohydrolases
  • dimethylargininase
  • Phosphopyruvate Hydratase